CCR5 genotype and plasma β-chemokine concentration of Brazilian HIV-infected individuals

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 11, 2002, Pages 1333-1337

  Mikawa, A Y ^a   Tagliavini, S A ^a   Costa, P I ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

CC chemokine receptor 5; Chemokines; HIV 1; 32ccr5 frequency allele

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ALLELE; ARTICLE; BLOOD DONOR; BLOOD LEVEL; BRAZIL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; GENE DELETION; GENOTYPE; HELPER CELL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SAMPLE; STATISTICAL ANALYSIS; VIRUS LOAD; VIRUS REPLICATION; VOLUNTEER;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036865454     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002001100011     Document Type: Article

References (19)

1. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allilmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R & O'Brien SJ (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273: 1856-1862.
2. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA & Landau NR (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86: 367-377.
3. Samson M, Libert F, Doranz B, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smith R, Collman R, Doms R, Vassart G & Parmentier M (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382: 722-725.
4. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM & Koup RA (1996). Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Medicine, 2: 412-417.
5. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brien SJ, Burny A & Gallo RC (1998). C-C chemokines, pivotal in protection against HIV type 1 infection. Proceedings of the National Academy of Sciences, USA, 95: 3857-3861.
6. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC & Lusso P (1995). Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science, 270: 1811-1815.
7. Mackenzie SW, Dallalio G, North M, Frame P & Means RT (1996). Serum chemokine levels in patients with non-progressing HIV infection. AIDS, 10: F29-F33.
8. Krowka JF, Gesner ML, Ascher MS & Sheppard HW (1997). Lack of associations of chemotatic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clinical Immunology and Immunopathology, 85: 21-27.
9. Kakkanaiah VN, Ojo-Amaize EA & Peter JB (1998). Concentrations of circulating β-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals. Clinical and Diagnostic Laboratory Immunology, 5: 499-502.
10. Yang JY, Togni M & Widmer U (1999). Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production. Cytokine, 11: 1-7.
11. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, Garzino-Demo A, Colombini-Hatch S, Margolis D & Gallo RC (2000). Higher macrophage inflammatory protein (MIP)-1α- and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proceedings of the National Academy of Sciences, USA, 97: 13812-13817.
12. Paxton WA, Neumann AU, Kang S, Deutch L, Brown RC, Koup RA & Wolinsky SM (2001). RANTES production form CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 progression. Journal of Infectious Diseases, 183: 1678-1681.
13. Miller SA, Dykes DD & Polesky HF (1998). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16: 1215.
14. Rubbert A, Combadiere C, Ostrowski M, Arthos J, Dybul M, Machado E, Cohn MA, Hoxie JA, Murphy PM, Fauci AS & Weissman D (1998). Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. Journal of Immunology, 160: 3033-3041.
15. Passos GAS & Picanço VP (1998). Frequency of the Accr5 deletion in the urban Brazilian population. Immunology Letters, 61: 205-207.
16. Martinson JJ, Chapman NH, Rees DC, Liu YT & Clegg JB (1997). Global distribution of the CCR5 gene 32-basepair deletion. Nature Genetics, 16: 100-103.
17. Picard L, Simmons G, Power CA, Meyer A, Weiss RA & Clapham PR (1997). Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. Journal of Virology, 71: 5003-5011.
18. Sharma V, Xu M, Ritter LM & Wilkie NM (1996). HIV-1 tat induces the expression of a new hematopoietic cell-specific transcription factor and downregulates MIP-1 alpha gene expression in activated T-cells. Biochemical and Biophysical Research Communications, 223: 526-533.
19. Aramori I, Ferguson SSG, Bieniasz PD, Cullen BR & Caron MG (1997). Molecular mechanism of desensitization of the chemokine receptor as an HIV-1 co-receptor. EMBO Journal, 16: 4606-4616.